-+ 0.00%
-+ 0.00%
-+ 0.00%

CURRUS BIOLOGICS ANNOUNCES FDA IND CLEARANCE FOR PHASE 1 TRIAL OF CUR-001 IN MESOTHELIN-POSITIVE ADVANCED REFRACTORY SOLID TUMOURS

Reuters·09/28/2026 22:01:08

Please log in to view news